Keywords: رزوواستاتین; Coronary artery disease; Rosuvastatin; Ezetimibe; Membrane fluidity; Oxidative stress;
مقالات ISI رزوواستاتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: رزوواستاتین; cardiovascular diseases; combination therapy; ezetimibe; LDL-C; rosuvastatin;
Keywords: رزوواستاتین; Arterial stiffness; Familial hypercholesterolemia; Rosuvastatin; Statins;
Keywords: رزوواستاتین; First derivative synchronous fluorescence spectrometry; Rosuvastatin; Propranolol;
Keywords: رزوواستاتین; Bioabsorbable bifurcation stents; Nanofibers; Rosuvastatin; Paclitaxel; In vitro release;
Keywords: رزوواستاتین; HILIC; Impurities; Rosuvastatin; Metformin; Method development; Method validation;
Keywords: رزوواستاتین; Acute kidney injury (AKI); statin; rosuvastatin; tubular toxicity; acute tubular necrosis;
Keywords: رزوواستاتین; Contrast-induced acute kidney injury (CI-AKI); contrast media; kidney disease; acute kidney failure; AKI prevention; statins; hydroxymethylglutaryl-CoA reductase inhibitor; statin; atorvastatin; rosuvastatin; simvastatin; N-acetylcysteine (NAC); serum cre
Keywords: رزوواستاتین; Losartan; Rosuvastatin; Carvedilol; Hydralazine; Left ventricular hypertrophy; Heart failure; Oxidative stress; Trx-1; Grx-3; Prx-2; Caspase-3; BNP;
Keywords: رزوواستاتین; Docosahexaenoic acid; Eicosapentaenoic acid; Hypertriglyceridemia; Omega-3 carboxylic acids; Pharmacokinetic interaction; Rosuvastatin; Simvastatin;
Keywords: رزوواستاتین; Atorvastatin; Clinical trials; Periodontal treatment; Rosuvastatin; Simvastatin; Statins; Systematic review;
Keywords: رزوواستاتین; Rosuvastatin; Ascorbic acid; Puberty; Male reproduction; Testis and epididymis;
Keywords: رزوواستاتین; Rosuvastatin; Bone healing; Stereological; Micro CT
Keywords: رزوواستاتین; Atorvastatin; Rosuvastatin; Type 2 diabetes; Immune restoration; In vivo CTL assay;
Keywords: رزوواستاتین; Drugs; Statins; Rosuvastatin; Aldol reaction; Asymmetric synthesis;
Keywords: رزوواستاتین; Ezetimibe; Rosuvastatin; Coronary artery plaque; High-sensitivity C-reactive protein; Interleukin-6; Matrix metalloproteinase-9
Keywords: رزوواستاتین; Resveratrol; Rosuvastatin; Diabetic nephropathy; Sirt1; FoxO1
Keywords: رزوواستاتین; Rosuvastatin; Intravascular ultrasonic elastography; Shear strain; Area strain; Vulnerable plaque; Rabbit model;
Keywords: رزوواستاتین; Rosuvastatin; Pulmonary delivery; Nanostructured lipid carrier; Dry powder for inhalation
Keywords: رزوواستاتین; Statins; Chronic heart failure; Moderate-intensity; Atorvastatin; Rosuvastatin; Simvastatin;
Keywords: رزوواستاتین; Rosuvastatin; Ticagrelor; Clopidogrel; CythocromesASA = acetylsalicylic acid, DAPT = dual antiplatelet therapy; PCI = percutaneous coronary intervention, HRPR = high-residual on-treatment platelet reactivity; MEA = multiple electrode aggregometry, ADP = a
Keywords: رزوواستاتین; Photocatalysis; Rosuvastatin; Byproducts; Toxicity;
Keywords: رزوواستاتین; Rosuvastatin; LDL subfractions; Cholesterol; Oxidized LDL; Adiponectin; hs-CRP; Carotid atherosclerosis;
Keywords: رزوواستاتین; Epidural fibrosis; Laminectomy; Rat; Rosuvastatin; Systemic; Topical
Keywords: رزوواستاتین; Rosuvastatin; Amlodipine; Human plasma; LC/MS/MS; Method validation; Pharmacokinetics
Keywords: رزوواستاتین; Biodegradable drug-eluting nanofibers; Rosuvastatin; Release characteristics; Re-endothelinization; Neointimal formation
Keywords: رزوواستاتین; angiogram; atorvastatin; CIN; contrast-induced acute kidney injury; contrast-induced nephropathy; coronary angiography; PCI; percutaneous coronary intervention; rosuvastatin; simvastatin; statins;
Keywords: رزوواستاتین; Statin; Atorvastatin; Rosuvastatin; Diabetic nephropathy; Podocyte; Urinary podocyte;
Keywords: رزوواستاتین; Simvastatin; Ezetimibe; Rosuvastatin; Lipoprotein associated phospholipase A2; Oxidative stress; Inflammation; Isoprostanes; Oxidized LDL;
Keywords: رزوواستاتین; Atorvastatin; Rosuvastatin; Statins; Renal function; Proteinuria;
Keywords: رزوواستاتین; combination drug; dyslipidemia; hypertension; olmesartan; pharmacokinetics; rosuvastatin;
Keywords: رزوواستاتین; Oxidative stress parameters; Rosuvastatin; Paroxetine; Citalopram; Rat
Keywords: رزوواستاتین; Ethanol; Myocardial infarction; Angiogenesis; Rosuvastatin; VEGF; Endostatin
Keywords: رزوواستاتین; Atherosclerosis; Metallothionein; Rosuvastatin; Zinc supplementation
Keywords: رزوواستاتین; atorvastatin; Brazil; cardiovascular; Colombia; cost-effectiveness; rosuvastatin; statins
Keywords: رزوواستاتین; atorvastatin; rosuvastatin; sepsis; simvastatin; statin; HR; hazard ratio; ICD-9-CM; International Classification of Diseases-9th Revision-Clinical Modification; LHID; Longitudinal Health Insurance Database; PS; propensity score;
Anti-hyperglycemic and anti-hyperlipidaemic effect of Arjunarishta in high-fat fed animals
Keywords: رزوواستاتین; Rosuvastatin; Type 2 diabetes; Insulin sensitizer genes; Arjunarishta;
Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability
Keywords: رزوواستاتین; Rosuvastatin; Cyclodextrin; Porous; Cross-linking; Pyromellitic dianhydride; Oral bioavailability;
Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial
Keywords: رزوواستاتین; combination; hypertriglyceridemia; non-HDL-C; Ï-3 fatty acids; rosuvastatin; triglycerides;
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE
Keywords: رزوواستاتین; ezetimibe; hypercholesterolemia; rosuvastatin; singe-pill combination;
Antinociception induced by rosuvastatin in murine neuropathic pain
Keywords: رزوواستاتین; Neuropathy; Antinociception; Rosuvastatin; Spinal cord biomarkers;
Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials
Keywords: رزوواستاتین; Apolipoprotein CIII; Statins; Cardiovascular disease; Atorvastatin; Rosuvastatin; Lovastatin;
A validated RP-HPLC method for the determination of rosuvastatin in presence of sacubitril/valsartan in rat plasma: Application to in vivo evaluation of OATP-mediated drug interaction potential between rosuvastatin and sacubitril/valsartan
Keywords: رزوواستاتین; HPLC; Organic anion-transporting polypeptide; Pharmacokinetic; Rosuvastatin; Sacubitril; Valsartan;
Rosuvastatin improves myocardial hypertrophy after hemodynamic pressure overload via regulating the crosstalk of Nrf2/ARE and TGF-β/ smads pathways in rat heart
Keywords: رزوواستاتین; Rosuvastatin; Cardiac hypertrophy; TGF-βl; Smad; Nrf2;
Preparation of novel phospholipid-based sonocomplexes for improved intestinal permeability of rosuvastatin: In vitro characterization, dynamic simulation, Caco-2 cell line permeation and in vivo assessment studies
Keywords: رزوواستاتین; Sonocomplexes; Ultrasound irradiation; Rosuvastatin; Phospholipid complexes; Caco-2 cell line;
Protective effects of rosuvastatin and vitamin E against fipronil-mediated oxidative damage and apoptosis in rat liver and kidney
Keywords: رزوواستاتین; Fipronil; Rosuvastatin; Vitamin E; Insecticides; Oxidative stress; Caspase-3;
Long circulating PEGylated-chitosan nanoparticles of rosuvastatin calcium: Development and in vitro and in vivo evaluations
Keywords: رزوواستاتین; Rosuvastatin; Chitosan; Nanoparticles; PEGylation; Atherosclerosis;
Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics
Keywords: رزوواستاتین; Rosuvastatin; Metabolomics; Lipidomics; Hyperlipidemia; Statin-induced myopathy;
Insights into hepatic and renal FXR/DDAH-1/eNOS pathway and its role in the potential benefit of rosuvastatin and silymarin in hepatic nephropathy
Keywords: رزوواستاتین; Cirrhosis; DDAH-1; FXR; Kidney; Rosuvastatin; Silymarin; ADMA; asymmetric dimethylarginine; ALK; Alkaline phosphatase; ALT; alaninetransaminase; AST; aspartate transaminase; CRD; Chronic Renal Disease; DDAH; dimethylarginine dimethylaminohydrolase-; ED; E
Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients
Keywords: رزوواستاتین; Dyslipidemia; Compliance; HMGCoA reductase; Atorvastatin; Rosuvastatin;